Coming Soon: Conexiant’s news site is becoming MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more.
Pediatrics
Partner With Us
Advertisement

Mental Health

thumb description

August 12, 2026

Redefining Fontan Care: The Socio-Economic Impact of SVHD on Families

Survey results reveal the long-term socio-economic and psychological impacts of single ventricle congenital heart disease (SVHD) on families. See how cardiologists Deepti Bhat, MD, and Naim Duran, MD, contributors to this research, are using findings to transform Fontan Clinic care at Phoenix Children’s.

Phoenix Children's Medical Connection

thumb description

August 11, 2026

Pediatric ADHD Stimulants Compared

A randomized open‐label trial detected no significant between‐group difference in short‐term symptom response, while a completer analysis found differences in weight change over 12 months.

MDSpire News

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

July 27, 2026

FDA Approves Centanafadine for ADHD

The first approved norepinephrine, dopamine, and serotonin reuptake inhibitor for ADHD demonstrated symptom improvements as early as week 1 in phase 3 trials.

MDSpire News

thumb description

July 17, 2026

ADHD Stimulant Misuse Under Review

High-frequency misuse remains associated with polysubstance use, while no studies evaluated long-term physical health outcomes.

MDSpire News